Pharmacy and drugs - search results: adderall xr


	About us	News	A-Z Drugs	Stores	Top Drugs	Contact

Diseases

.: Addiction
.: ADHD
.: Allergies
.: Alzheimers disease
.: Angina
.: Arthritis
.: Asthma
.: Bacterial infection
.: Birth control
.: Blood disorder
.: Breast cancer
.: Cancer
.: Diabetes
.: Digestive system
.: Ear infections
.: Erectile dysfunction
.: Eye diseases
.: Fever
.: Gastro problems
.: Glaucoma
.: Heart diseases
.: Hormones
.: Infectious diseases
.: Joint pain
.: Kidney stones
.: Lung cancer
.: Lung diseases
.: Mental Health and Depression
.: Mouth diseases
.: Neurological disorder
.: Pain relief
.: Reduce cholesterol
.: Skin diseases
.: Sleep disorder
.: Std
.: Supplement
.: Urinary tract infection
.: Weight loss
.: Womens health

Newsletter

Subscribe to our newsletter:

Name:
E-mail:

Search results

Search results for: adderall xr
1 - 1 of 1 <<previous | next>>

Drugs results:

Adderall

Adderall (also known as Dextroamphetamine and amphetamine) is one of a group of medicines known as Central Nervous System (CNS) stimulants. They are used to treat Attention-Deficit Hyperactivity Disorder (ADHD). Amphetamines are also more...

Diseases results:

Sleep disorder

Articles results:

Novel Treatment For ADHD - Shire And New River Pharmaceuticals Announce FDA Approval Of The First And Only Stimulant Prodrug VYVANSE

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) and its collaborative partner New River Pharmaceuticals Inc. (NASDAQ: NRPH) announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). On February 20, 2007 Shire and New River announced an agreement whereby Shire will acquire New River for approximately $2.

1 - 1 of 1 <<previous | next>>